Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12251387
APP PUB NO 20230277547A1
SERIAL NO

18175515

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are compounds of Formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • VERTEX PHARMACEUTICALS INCORPORATED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Charifson, Paul S Framingham, US 67 1094
Cottrell, Kevin Michael Cambridge, US 32 346
Court, John J Littleton, US 39 449
Deng, Hongbo Southborough, US 72 868
Giroux, Simon Cambridge, US 45 459
Gu, Wenxin Concord, US 36 412
Jackson, Katrina Lee Cambridge, US 23 390
Lauffer, David J Stow, US 78 1914
Li, Pan Lexington, US 213 2446
Maxwell, John Patrick Hingham, US 34 392
Morris, Mark A Somerville, US 30 357
Pierce, Albert Charles Cambridge, US 28 536
Ronkin, Steven M Watertown, US 35 910
Tang, Qing Boston, US 82 1559
Waal, Nathan D Cambridge, US 34 371
Xu, Jinwang Boston, US 41 602

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 18, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 18, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 18, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00